Developer docs
API playgroundTry for free, no card

Search company profiles

Addgene

Full company profile

uuid0005jeu

Namestring
Addgene
Legal namestring
Addgene
Websiteurl
addgene.org
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Addgene is a nonprofit biological resource repository founded in 2004 and headquartered in Watertown, Massachusetts. The organization operates as a centralized archive and global distribution platform for research materials, currently holding 174,400+ plasmids contributed by 6,962 laboratories worldwide. Its catalog also includes 1,091 ready-to-use viral vectors (AAV, lentivirus, adenovirus, gamma-retrovirus), 275 recombinant antibodies, pooled CRISPR libraries, and plasmid kits. Materials have been requested 2,444,665 times and shipped to 113 countries, with the organization having played a documented role in enabling CRISPR research and COVID-19 vaccine development.

The platform is built around a self-serve digital ordering system in which researchers browse the catalog online, complete Material Transfer Agreements (MTAs) electronically, and receive verified materials with full sequence documentation. Supporting infrastructure includes a BLAST-based Sequence Analyzer, a user-contributed Data Hub for experimental validation, a Vector Database, and a Developers Portal exposing API access. Vertical service offerings include AAV and lentivirus packaging on request or from in-stock inventory, custom serotype preparation, and cloning-grade DNA preparation. Tech Transfer Accounts allow institutions to manage approvals, track transfers, and download executed MTAs digitally.

Addgene generates revenue primarily through transaction fees on material distribution and viral preparation services, charging customers to cover storage, verification, and distribution costs. Customer segments span academic and nonprofit researchers (primary) and a growing industry channel served via a dedicated Industry Portal with distinct licensing terms for for-profit biotech and pharmaceutical companies. The organization is led by President and Executive Director Chonnettia Jones and announced a refreshed brand identity in April 2026 reflecting its evolution beyond plasmid-only distribution and its strategic prioritization of industry partnerships.

Short descriptiontext

Addgene is a nonprofit biological resource repository that archives, verifies, and globally distributes plasmids, viral vectors, and recombinant antibodies from 6,962 contributing labs to researchers in 113 countries, primarily serving academic and nonprofit life-science institutions with a growing industry channel.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWatertown, United States
HQ citystring
Watertown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
plasmid repository services, viral vector preparation, recombinant antibody distribution, molecular biology reagents, research materials sharing
Industry5 codes
PRIMARYHLAAACAB
Lentiviral Vector Gene Therapy Developers
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAACAA
AAV Vector Gene Therapy Developers
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAACAN
Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAGABAE
Gene Therapy (Viral Vector/Plasmid) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAAKAE
Plasmid DNA & mRNA Manufacturing Services
Product category
Biological Research Materials Repository and Distribution
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Research Materials Distribution
TypeTransaction Fee
Description

Distribution of plasmids, viral vectors, and antibodies to academic and industry researchers worldwide. The nonprofit charges fees for materials to cover storage, verification, and distribution costs while maintaining accessibility for academic institutions.

addgene.org
2Viral Preparation Services
TypeTransaction Fee
Description

Fee-based preparation and packaging of viral vectors including AAV and lentivirus on request or from in-stock inventory

addgene.org
3Industry Access Fees
TypeTransaction Fee
Description

Industry customers pay for access to certain materials and services, with Addgene noting a subset of collection available for for-profit entities

pulse2.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Addgene is a nonprofit biological material repository and distribution platform that archives, verifies, and globally distributes plasmids, viral vectors, and recombinant antibodies on behalf of contributing laboratories. It manages the full ordering, Material Transfer Agreement (MTA), and shipping workflow for materials shipped to 113 countries, and complements physical distribution with a digital toolkit including a Sequence Analyzer, Data Hub, Vector Database, and Developers Portal API.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 174,400+ plasmids distributed to researchers worldwide
+2 more records
Product overview1 text field

Addgene is a nonprofit biological resource organization operating as a centralized repository and distribution service for research materials. The organization functions as both a platform and service provider, offering plasmids as the foundational product alongside viral vectors (AAV and Lentivirus preparations), recombinant antibodies, pooled CRISPR libraries, and plasmid kits. Supporting infrastructure includes Data Hub for user-contributed validation data, Sequence Analyzer and Vector Database for research tools, and a Developers Portal providing API access to repository data. The company supports the global research community by managing material transfers through Material Transfer Agreements (MTAs) and providing educational content including protocols and science guides. Materials have been requested over 2.4 million times and shipped to 113 countries.

Product and service8 records
1Plasmid Repository and Distribution
CategoryPlasmid Repository
Description

Centralized archive and global distribution of 174,400+ plasmids contributed by 6,962 laboratories, with full sequence documentation, quality verification, and Material Transfer Agreement handling for researchers worldwide.

2Viral Vectors (AAV, Lentivirus, Adenovirus, γ-Retrovirus)
CategoryViral Vectors
Description

Ready-to-use viral preparations including AAV, Lentivirus, Adenovirus, and γ-Retrovirus vectors, comprising 1,091 ready-to-use items distributed to researchers for viral research and gene delivery applications.

3Recombinant Antibodies
CategoryRecombinant Antibodies
Description

Distribution of 275 recombinant antibodies, including chimeric recombinant antibodies with fused variable and constant domains, for research applications in immunology and related fields.

4Pooled CRISPR Libraries
CategoryPooled CRISPR Libraries
Description

Genome-wide CRISPR screening libraries available as ready-to-use viral preparations for genetic screening applications.

5Plasmid Kits
CategoryPlasmid Kits
Description

Pre-configured collections of related plasmids bundled together for convenience, allowing researchers to request multiple related constructs in a single order.

6AAV Prep Service
CategoryViral Prep Service
Description

Adeno-Associated Virus preparation services including in-stock AAV particles, packaged-on-request preparations, and custom serotypes (Caltech Systemic, Retrograde, University of Florida Eye Panel).

7Lentivirus Prep Service
CategoryViral Prep Service
Description

Lentiviral vector preparation services including Cas9 constructs, pooled CRISPR libraries, and non-CRISPR options available as ready-to-use preparations.

8Cloning Grade DNA Service
CategoryDNA Service
Description

High-purity DNA preparation service for cloning applications, providing researchers with ready-to-use DNA for downstream molecular biology workflows.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Allen Institute for Cell Science is listed as a community partner on Addgene's platform, indicating collaborative relationship for sharing cell biology research materials and promoting open science initiatives.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Addgene announced strategic prioritization of industry partnerships to broaden access to reliable research materials as part of its 2026 brand refresh, indicating expanded commercial distribution relationships.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Commercial provider of custom plasmid design, viral vector packaging (AAV, lentivirus, adenovirus), and engineered cell lines. Most directly competitive to Addgene's viral vector preparation services across academic and biotech customers.

TypeBroad incumbent
Description

Global life sciences tools and reagents company offering plasmids, cloning tools, gene synthesis, and viral vectors through brands like Invitrogen and Thermo Scientific. Reaches the same researcher customer base via a much broader product portfolio.

TypeDirect peer
Description

Major manufacturer of DNA and RNA oligonucleotides, genes, and supporting reagents serving the same academic and biotech researcher base. Provides on-demand synthesis alternatives to the plasmid-retrieval workflow that Addgene enables.

TypeBroad incumbent
Description

Large contract research and CDMO organization with end-to-end gene therapy and cell therapy manufacturing capabilities. Provides comparable plasmid and viral vector services as part of a much broader portfolio targeting industry customers.

TypeDirect peer
Description

Commercial DNA synthesis company offering synthetic genes, plasmids, and antibody libraries to researchers. Competes with Addgene's plasmid catalog through on-demand gene synthesis that bypasses the need to retrieve physical materials.

TypeDirect peer
Description

Global life sciences services company offering gene synthesis, plasmid preparation, viral vector packaging, and protein production. Directly competes with Addgene on plasmid manufacturing and viral vector services for academic and industry customers.

TypeDirect peer
Description

Nonprofit biological resource center that authenticates, stores, and distributes cell lines, microbes, and biomaterials to researchers worldwide. Operates the same nonprofit-repository model as Addgene for an adjacent product category, making it the closest structural peer.

TypeDirect peer
Description

CDMO specializing in plasmid DNA, mRNA, and protein production for therapeutic and research applications. Competes with Addgene's plasmid and viral vector services, particularly for higher-quality and GMP-grade industry customers.

TypeDirect peer
Description

Nonprofit biomedical research organization that maintains and distributes cell lines, DNA samples, and biological specimens to the research community. Closely mirrors Addgene's nonprofit repository and distribution model for an adjacent product set.

10System Biosciences (SBI)
TypeEmerging player
Description

Specialty provider of plasmids, lentiviral vectors, and molecular biology tools focused on genomics and gene editing research. Smaller and more niche than GenScript or Aldevron but directly comparable to Addgene's core catalog offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Addgene

Biological Research Materials Repository and Distributionaddgene.org

Addgene is a nonprofit biological resource repository that archives, verifies, and globally distributes plasmids, viral vectors, and recombinant antibodies from 6,962 contributing labs to researchers in 113 countries, primarily serving academic and nonprofit life-science institutions with a growing industry channel.

What Addgene does

Addgene is a nonprofit biological resource repository founded in 2004 and headquartered in Watertown, Massachusetts. The organization operates as a centralized archive and global distribution platform for research materials, currently holding 174,400+ plasmids contributed by 6,962 laboratories worldwide. Its catalog also includes 1,091 ready-to-use viral vectors (AAV, lentivirus, adenovirus, gamma-retrovirus), 275 recombinant antibodies, pooled CRISPR libraries, and plasmid kits. Materials have been requested 2,444,665 times and shipped to 113 countries, with the organization having played a documented role in enabling CRISPR research and COVID-19 vaccine development.

The platform is built around a self-serve digital ordering system in which researchers browse the catalog online, complete Material Transfer Agreements (MTAs) electronically, and receive verified materials with full sequence documentation. Supporting infrastructure includes a BLAST-based Sequence Analyzer, a user-contributed Data Hub for experimental validation, a Vector Database, and a Developers Portal exposing API access. Vertical service offerings include AAV and lentivirus packaging on request or from in-stock inventory, custom serotype preparation, and cloning-grade DNA preparation. Tech Transfer Accounts allow institutions to manage approvals, track transfers, and download executed MTAs digitally.

Addgene generates revenue primarily through transaction fees on material distribution and viral preparation services, charging customers to cover storage, verification, and distribution costs. Customer segments span academic and nonprofit researchers (primary) and a growing industry channel served via a dedicated Industry Portal with distinct licensing terms for for-profit biotech and pharmaceutical companies. The organization is led by President and Executive Director Chonnettia Jones and announced a refreshed brand identity in April 2026 reflecting its evolution beyond plasmid-only distribution and its strategic prioritization of industry partnerships.

Addgene firmographics

Firmographics
Name
Addgene
Legal name
Addgene
Website
https://addgene.org
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
101–250 employees
Short description
Addgene is a nonprofit biological resource repository that archives, verifies, and globally distributes plasmids, viral vectors, and recombinant antibodies from 6,962 contributing labs to researchers in 113 countries, primarily serving academic and nonprofit life-science institutions with a growing industry channel.
Ownership category
akta.pro rank

Addgene industry classification

Industry
Product category
Biological Research Materials Repository and Distribution
akta.pro industry
PRIMARYHLAAACAB
Lentiviral Vector Gene Therapy Developers
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAACAA
AAV Vector Gene Therapy Developers
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAAACAN
Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream)
Healthcare & Life Sciences/Biotechnology & Biologics/Gene Therapy (AAV/lentiviral/other vectors)
SECONDARYHLAGABAE
Gene Therapy (Viral Vector/Plasmid) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAAAKAE
Plasmid DNA & mRNA Manufacturing Services

Keywords

  • Plasmid repository services
  • Viral vector preparation
  • Recombinant antibody distribution
  • Molecular biology reagents
  • Research materials sharing

Where Addgene is headquartered

Location

Headquarters

HQ city
Watertown
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Addgene business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Research Materials Distribution: Distribution of plasmids, viral vectors, and antibodies to academic and industry researchers worldwide. The nonprofit charges fees for materials to cover storage, verification, and distribution costs while maintaining accessibility for academic institutions.
  2. Viral Preparation Services: Fee-based preparation and packaging of viral vectors including AAV and lentivirus on request or from in-stock inventory
  3. Industry Access Fees: Industry customers pay for access to certain materials and services, with Addgene noting a subset of collection available for for-profit entities

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Addgene product offering

Product offering

Core offering

Addgene is a nonprofit biological material repository and distribution platform that archives, verifies, and globally distributes plasmids, viral vectors, and recombinant antibodies on behalf of contributing laboratories. It manages the full ordering, Material Transfer Agreement (MTA), and shipping workflow for materials shipped to 113 countries, and complements physical distribution with a digital toolkit including a Sequence Analyzer, Data Hub, Vector Database, and Developers Portal API.

Product overview

Addgene is a nonprofit biological resource organization operating as a centralized repository and distribution service for research materials. The organization functions as both a platform and service provider, offering plasmids as the foundational product alongside viral vectors (AAV and Lentivirus preparations), recombinant antibodies, pooled CRISPR libraries, and plasmid kits. Supporting infrastructure includes Data Hub for user-contributed validation data, Sequence Analyzer and Vector Database for research tools, and a Developers Portal providing API access to repository data. The company supports the global research community by managing material transfers through Material Transfer Agreements (MTAs) and providing educational content including protocols and science guides. Materials have been requested over 2.4 million times and shipped to 113 countries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Plasmid Repository and Distribution Centralized archive and global distribution of 174,400+ plasmids contributed by 6,962 laboratories, with full sequence documentation, quality verification, and Material Transfer Agreement handling for researchers worldwide.
  • Viral Vectors (AAV, Lentivirus, Adenovirus, γ-Retrovirus) Ready-to-use viral preparations including AAV, Lentivirus, Adenovirus, and γ-Retrovirus vectors, comprising 1,091 ready-to-use items distributed to researchers for viral research and gene delivery applications.
  • Recombinant Antibodies Distribution of 275 recombinant antibodies, including chimeric recombinant antibodies with fused variable and constant domains, for research applications in immunology and related fields.
  • Pooled CRISPR Libraries Genome-wide CRISPR screening libraries available as ready-to-use viral preparations for genetic screening applications.
  • Plasmid Kits Pre-configured collections of related plasmids bundled together for convenience, allowing researchers to request multiple related constructs in a single order.
  • AAV Prep Service Adeno-Associated Virus preparation services including in-stock AAV particles, packaged-on-request preparations, and custom serotypes (Caltech Systemic, Retrograde, University of Florida Eye Panel).
  • Lentivirus Prep Service Lentiviral vector preparation services including Cas9 constructs, pooled CRISPR libraries, and non-CRISPR options available as ready-to-use preparations.
  • Cloning Grade DNA Service High-purity DNA preparation service for cloning applications, providing researchers with ready-to-use DNA for downstream molecular biology workflows.

Quantifiable outcome

  • 174,400+ plasmids distributed to researchers worldwide
  • +2 more outcomes

Companies that use Addgene

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Addgene technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Addgene partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Allen Institute for Cell SciencecoreStrategic or Co-development PartnerAllen Institute for Cell Science is listed as a community partner on Addgene's platform, indicating collaborative relationship for sharing cell biology research materials and promoting open science initiatives.
  • Industry PartnerscoreChannel Partner/ Reseller/ DistributorAddgene announced strategic prioritization of industry partnerships to broaden access to reliable research materials as part of its 2026 brand refresh, indicating expanded commercial distribution relationships.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Addgene competitors and assessment

Company assessment

Direct peers

  • VectorBuilder: Commercial provider of custom plasmid design, viral vector packaging (AAV, lentivirus, adenovirus), and engineered cell lines. Most directly competitive to Addgene's viral vector preparation services across academic and biotech customers.
  • Integrated DNA Technologies (IDT): Major manufacturer of DNA and RNA oligonucleotides, genes, and supporting reagents serving the same academic and biotech researcher base. Provides on-demand synthesis alternatives to the plasmid-retrieval workflow that Addgene enables.
  • Twist Bioscience: Commercial DNA synthesis company offering synthetic genes, plasmids, and antibody libraries to researchers. Competes with Addgene's plasmid catalog through on-demand gene synthesis that bypasses the need to retrieve physical materials.
  • GenScript: Global life sciences services company offering gene synthesis, plasmid preparation, viral vector packaging, and protein production. Directly competes with Addgene on plasmid manufacturing and viral vector services for academic and industry customers.
  • ATCC (American Type Culture Collection): Nonprofit biological resource center that authenticates, stores, and distributes cell lines, microbes, and biomaterials to researchers worldwide. Operates the same nonprofit-repository model as Addgene for an adjacent product category, making it the closest structural peer.
  • Aldevron: CDMO specializing in plasmid DNA, mRNA, and protein production for therapeutic and research applications. Competes with Addgene's plasmid and viral vector services, particularly for higher-quality and GMP-grade industry customers.
  • Coriell Institute: Nonprofit biomedical research organization that maintains and distributes cell lines, DNA samples, and biological specimens to the research community. Closely mirrors Addgene's nonprofit repository and distribution model for an adjacent product set.

Broad incumbents

  • Thermo Fisher Scientific: Global life sciences tools and reagents company offering plasmids, cloning tools, gene synthesis, and viral vectors through brands like Invitrogen and Thermo Scientific. Reaches the same researcher customer base via a much broader product portfolio.
  • Charles River Laboratories: Large contract research and CDMO organization with end-to-end gene therapy and cell therapy manufacturing capabilities. Provides comparable plasmid and viral vector services as part of a much broader portfolio targeting industry customers.

Emerging players

  • System Biosciences (SBI): Specialty provider of plasmids, lentiviral vectors, and molecular biology tools focused on genomics and gene editing research. Smaller and more niche than GenScript or Aldevron but directly comparable to Addgene's core catalog offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Addgene social profiles

Digital presence

Addgene financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Addgene leadership team

Management profile

Number of profiles

Profiles4 records

Addgene funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Addgene M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Addgene

What does Addgene do?

Addgene is a nonprofit biological material repository and distribution platform that archives, verifies, and globally distributes plasmids, viral vectors, and recombinant antibodies on behalf of contributing laboratories. It manages the full ordering, Material Transfer Agreement (MTA), and shipping workflow for materials shipped to 113 countries, and complements physical distribution with a digital toolkit including a Sequence Analyzer, Data Hub, Vector Database, and Developers Portal API.

Is Addgene a public or private company?

Addgene is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Addgene founded?

Addgene was founded in 2004. It employs 101 to 250 people.

Where is Addgene based?

Addgene is headquartered in Watertown, United States, in the North America region.

How does Addgene make money?

Three revenue lines are on record. Research Materials Distribution is the primary driver. The others are viral Preparation Services and industry Access Fees.

Who are Addgene's main competitors?

Direct peers on record are VectorBuilder, Integrated DNA Technologies (IDT), Twist Bioscience, GenScript, ATCC (American Type Culture Collection), Aldevron and Coriell Institute. Broad incumbents are Thermo Fisher Scientific and Charles River Laboratories. System Biosciences (SBI) is listed as an emerging player.

Does Addgene have an API?

Yes. Addgene provides a Developers Portal offering API access to plasmid and sequence data. The portal enables programmatic access to Addgene's repository data, including plasmid sequences, metadata, and deposit information. The API allows developers to integrate Addgene's biological material database into their research workflows. BLAST search functionality is available as part of the Search by Sequence feature. Developer documentation is at developers.addgene.org.

What industry is Addgene in?

Addgene's product category is Biological Research Materials Repository and Distribution. Its primary akta.pro industry code is HLAAACAB, Lentiviral Vector Gene Therapy Developers, with a secondary code of HLAAACAA, AAV Vector Gene Therapy Developers.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialAddgene Integrates Plasmid And Viral Prep Catalog Into Anthropic's Claude For Life SciencesAddgene launched an MCP connector to integrate its plasmid and viral prep catalog into Anthropic's Claude for Life Sciences. The catalog contains over 177,000 plasmids and 1,000 viral vectors, with read-only access for Claude. Addgene plans to expand the catalog's reach.FinancialContent Business PageAddgene Integrates Plasmid and Viral Prep Catalog into Anthropic’s Claude for Life SciencesAddgene launched an MCP connector to integrate its plasmid and viral prep catalog into Anthropic's Claude for Life Sciences. The connector grants read-only access to over 177,000 plasmids and 1,000 viral vectors, allowing users to search and download sequences within Claude.GlobeNewswireAddgene Integrates Plasmid and Viral Prep Catalog into Anthropic’s Claude for Life SciencesAddgene launched an MCP connector to integrate its plasmid and viral prep catalog into Anthropic's Claude for Life Sciences. The catalog contains over 177,000 plasmids and 1,000 viral vectors, with read-only access for Claude. Addgene plans to explore expanding the catalog's reach.GlobeNewswireAddgene Reinforces Its Expanding Role in Research with New BrandAddgene announced a refreshed brand reflecting its expanded services, including plasmids, viral vectors, and recombinant antibodies. The organization, founded as a nonprofit plasmid repository, now offers educational resources and data, and continues to diversify its catalog and prioritize industry partnerships.GlobeNewswireAddgene Reinforces Its Expanding Role in Research with New BrandAddgene, a nonprofit research materials organization headquartered in Watertown, Massachusetts, announced a refreshed brand identity reflecting its expanded services and strategic growth since its founding as a plasmid repository. The organization has evolved to offer plasmids, viral vectors, recombinant antibodies, and educational resources, having supported foundational CRISPR research and COVID-19 vaccine development. Addgene stated it will continue diversifying its catalog and prioritizing industry partnerships to broaden access to reliable research materials.GlobeNewswireAddgene and Plasmidsaurus Announce Strategic Partnership to Scale Sequencing for Leading Plasmid RepositoryAddgene and Plasmidsaurus announced a four-year strategic partnership to scale whole plasmid sequencing for Addgene's repository. Plasmidsaurus will handle 95% of Addgene's sequencing, using long-read technology to achieve >99.9% basecall accuracy and consensus accuracy above Q60. The collaboration aims to maintain high-quality data while keeping operations cost-effective as the collection grows.GlobeNewswireAddgene Appoints Greg Crescenzi as Vice President of Global Commercial Strategy and PartnershipsAddgene appointed Greg Crescenzi as Vice President of Global Commercial Strategy and Partnerships. He will drive business development and execute a mission-aligned commercial strategy across global customer segments. The organization offers over 170,000 plasmids, viral vectors, and antibodies to researchers.Pulse 2.0Addgene: Interview With President And Executive Director Chonnettia Jones About The NonprofitPulse 2.0 interviewed Addgene President and Executive Director Chonnettia Jones about the nonprofit biological resource organization that accelerates scientific discovery by providing researchers worldwide with documented plasmids, viral vectors, and recombinant antibodies. Founded in 2004, Addgene has distributed over 158,000 plasmids from more than 6,400 labs globally and played a pivotal role in rapid CRISPR technology adoption and COVID-19 research efforts. Jones acknowledged that recent sweeping cuts to US scientific funding represent unprecedented challenges threatening the research ecosystem, while emphasizing Addgene's vital role in supporting scientists during constrained funding periods through material archiving and affordable authenticated research materials.GlobeNewswireAddgene Announces Strategic Partnership with Promega to Launch Plasmid CollectionAddgene announced a partnership with Promega to launch the Promega Plasmid Collection, adding 300 plasmids in traditional bacterial or purified DNA format. The collection targets drug discovery and pathway biology, with an estimated 300 additional plasmids planned for release in coming months.GlobeNewswireAddgene Adds Science and Tech Leaders to Its Management Team and Board of DirectorsAddgene announced new management and board appointments on April 16, 2025, including Eleanor Kolossovski as VP of Global Business Strategy, Luk H. Vandenberghe as Board Chair, and others. The appointments support Addgene's growth strategy and market expansion in the life sciences sector.